Targeting tumor metabolic flexibility enhances radiotherapeutic efficacy via mitochondrial complex I Inhibition in an intracranial S180 sarcoma mouse model

Radiotherapy (RT) eliminates cancer cells by inducing DNA damage. However, its efficacy is often reduced by mechanisms such as radiation resistance, effective DNA repair, and hypoxia within tumors. Tumor cells utilize metabolic flexibility, dynamically switching between glycolysis and oxidative phosphorylation (OXPHOS) to survive and resist RT-induced stress. This study investigates how inhibiting mitochondrial complex I (CI) with IACS-010759 (IACS) enhances tumor cell sensitivity to RT, with a particular focus on metabolic disruption, DNA damage response, and overall cell survival. The potentiated effects of IACS combined with RT were evaluated in S-180 sarcoma cells using four experimental groups: control, IACS, RT, and RT + IACS. Apoptosis proteins (BAX, BCL-2, cleaved caspase-3) and radiosensitivity markers (SOD2, γH2AX) were analyzed via Western blot. ROS levels were measured by fluorescence, cell cycle by EdU-incorporated flow cytometry, p53 and p21 via Western blot, and stemness by sphere formation. In vivo, mouse intracranial tumor models underwent MRI-based tumor monitoring and survival assessment. The RT + IACS group showed heightened apoptosis via BAX/BCL-2 and caspase-3 activation, reduced SOD2, elevated ROS, and persistent γH2AX, indicating impaired DNA repair. Cell cycle analysis indicated G1/G2 phase arrest, which was associated with increased p53 and p21 expression levels, indicating p53/p21-mediated regulation, and stemness was reduced. MRI indicated the greatest tumor reduction and improved survival in the RT + IACS group. The combination of RT with metabolic inhibition effectively disrupts metabolic flexibility in S180 sarcoma, leading to ROS accumulation, impaired DNA repair, enhanced apoptosis, and reduced tumor stemness. Targeting tumor cell metabolism represents a promising strategy for enhancing RT efficacy by overcoming multiple resistance mechanisms.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-28
DOI
https://doi.org/10.1038/s41598-025-29326-2
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting tumor metabolic flexibility enhances radiotherapeutic efficacy via mitochondrial complex I Inhibition in an intracranial S180 sarcoma mouse model

Shin Jung, Zhipeng Liu, Sa-Hoe Lim
Scientific Reports
Cancer, Hypoxia, and Metabolism
article

Targeting tumor metabolic flexibility enhances radiotherapeutic efficacy via mitochondrial complex I Inhibition in an intracranial S180 sarcoma mouse model

Shin Jung, Zhipeng Liu, Sa-Hoe Lim
article en

Abstract

Radiotherapy (RT) eliminates cancer cells by inducing DNA damage. However, its efficacy is often reduced by mechanisms such as radiation resistance, effective DNA repair, and hypoxia within tumors. Tumor cells utilize metabolic flexibility, dynamically switching between glycolysis and oxidative phosphorylation (OXPHOS) to survive and resist RT-induced stress. This study investigates how inhibiting mitochondrial complex I (CI) with IACS-010759 (IACS) enhances tumor cell sensitivity to RT, with a particular focus on metabolic disruption, DNA damage response, and overall cell survival. The potentiated effects of IACS combined with RT were evaluated in S-180 sarcoma cells using four experimental groups: control, IACS, RT, and RT + IACS. Apoptosis proteins (BAX, BCL-2, cleaved caspase-3) and radiosensitivity markers (SOD2, γH2AX) were analyzed via Western blot. ROS levels were measured by fluorescence, cell cycle by EdU-incorporated flow cytometry, p53 and p21 via Western blot, and stemness by sphere formation. In vivo, mouse intracranial tumor models underwent MRI-based tumor monitoring and survival assessment. The RT + IACS group showed heightened apoptosis via BAX/BCL-2 and caspase-3 activation, reduced SOD2, elevated ROS, and persistent γH2AX, indicating impaired DNA repair. Cell cycle analysis indicated G1/G2 phase arrest, which was associated with increased p53 and p21 expression levels, indicating p53/p21-mediated regulation, and stemness was reduced. MRI indicated the greatest tumor reduction and improved survival in the RT + IACS group. The combination of RT with metabolic inhibition effectively disrupts metabolic flexibility in S180 sarcoma, leading to ROS accumulation, impaired DNA repair, enhanced apoptosis, and reduced tumor stemness. Targeting tumor cell metabolism represents a promising strategy for enhancing RT efficacy by overcoming multiple resistance mechanisms.

Scientific ReportsVol. 15(1)
Chonnam National University (KR), Chonnam National University Hospital (KR), Ningbo No. 2 Hospital (CN), Chonnam National University Hwasun Hospital (KR), Ningbo No.6 Hospital (CN)
Mike and Josie Harper Cancer Research Institute, Chonnam National University, Chonnam National University Hwasun Hospital
Openalex Percentile: Top 54%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.